Your browser doesn't support javascript.
loading
AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.
Verma, Kshitij; Gupta, Nehal; Zang, Tianzhu; Wangtrakluldee, Phumvadee; Srivastava, Sanjay K; Penning, Trevor M; Trippier, Paul C.
Afiliação
  • Verma K; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, Texas.
  • Gupta N; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, Texas.
  • Zang T; Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wangtrakluldee P; Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Srivastava SK; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, Texas.
  • Penning TM; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, Abilene, Texas.
  • Trippier PC; Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Mol Cancer Ther ; 17(9): 1833-1845, 2018 09.
Article em En | MEDLINE | ID: mdl-29891491
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores Enzimáticos / Membro C3 da Família 1 de alfa-Ceto Redutase / Antineoplásicos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores Enzimáticos / Membro C3 da Família 1 de alfa-Ceto Redutase / Antineoplásicos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article